LINC01194 and plasma cell myeloma: The present study aimed to progress our previous work (1, 6–8, 10, 11) and investigate the ability of hybrid cell lines, produced by fusion of HMy2 cells and myeloma cells, to induce HLA-A2-restricted tumor antigen-specific cytotoxic T cells (ASCTL) in vitro, in PBLs from patients with multiple myeloma.